IFN-γinterferon-gammabreast cancerimmunotherapy
…ch as LPS, or to bacteria in combination with interferon-gamma (IFN-γ).Results Based on the results obtained by fluorescent microscop…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 961–1,020 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
mineralocorticoid receptor antagonist4mycophenolic acid4opioid medications4paroxetine4polyethylene glycol4prednisone-equivalent4quinolones4tenofovir disoproxil fumarate4thyroxine4topical steroids4SACT3Suvorexant3hrHPV3mFOLFIRINOX3Sitravatinib3S-13CGRP3Phentermine3Phe3Enpatoran3UACR3Obesity medications3DZP3ANI3BA3ACP3AB5983DXM3MDI3TK-63023IMA2033MRX3PDS01ADC3UPA303AKK3UPA153Vastrax3hs-CRP3177Lu-PSMA3DMPA-SC3Delamanid3OBZ3Oestradiol3Zilucoplan3DeepSeek-R13Depemokimab3FIB43HX1113Succinate32-Chloroprocaine3ARB3Cr(VI)3Cystatin C3Fisetin3PIM3SZC3Dalbavancin3KSQ-004EX3LTX-3153Migalastat3
Articles mentioning drugs
10,506 articles · page 566 of 876mammalian target of rapamycinbreast cancer
…f phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT), mammalian target of rapamycin (mTOR), forkhead box O (FOXO), mouse double minute 2 homolog (M…
LRK-4189LRK-4189-mediatedCRO
… and effectively targeted in vivo using a bifunctional degrader.LRK-4189 is currently in IND-enabling studies and will enter clinical tr…
PPmGenUniversity of Houstongastric cancerNational Institutes of HealthPIK3CA-associated breast cancerlung cancertriple-negative breast cancer
…n-HLA was predicted with TL-MHC17 and CrossDome.18 We developed PPmGen to generate APLs with single and double-point mutations for eac…
Ova257-264 SIINFEKLgp100/pmel 17Weill Cornell Medical CollegeimmunotherapyImmunogenic tumorslung adenocarcinomasJ Exp Med
…d for 48 hours with plate-bound antibodies or native or APLs of Ova257-264 SIINFEKL were phenotyped by flow cytometryAbstract 1296 Figure 2Principa…
pembrolizumabAmerican Italian Cancer Foundationnon-small cell lung cancerALK + lymphoma
…d neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, p…
86.6%
anti-CTLA4checkpoint inhibitorsmelanomaThe Cancer Genome AtlasGene Expression Omnibus
…ssociated with favorable outcomes only in patients treated with anti-CTLA4 (p<0.05). ScRNA analysis revealed elevated expression of NLRC5 …
immune checkpoint inhibitorICISamsung Medical CenterSeoul National University HospitalDiscovery Life Sciencesimmunotherapy
…tational Burden (TMB) has emerged as a predictive biomarker for immune checkpoint inhibitor (ICI) response across multiple cancer types. However, current c…
phorbol 12-myristate 13-acetateionomycinT cell-targeted immunotherapiescancer immunotherapies
…unctionality, NFAT-luciferase T cell lines were stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin, while NF-κB-luciferase myeloid lines were …
TG4050piplelinesolid tumorsbreast cancerNational Whole-Genome Project in JapanAMED
… A, e t al. Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative…
pembrolizumabnivolumabresectable non-small-cell lung cancerresectable non-small cell lung cancerresectable lung cancerN Engl J MedNSCLCNSCLCpCRNeoadjuvant/perioperative chemoimmunotherapylung cancer
…berman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med. 2023 …
BTN3A1 antibodyBristol Myers Squibb
…cell treatment either alone or in combination with an agonistic BTN3A1 antibody at a concentration that achieved 20–40% growth inhibition relat…